European Academy of Allergy and Clinical Immunology
EAACI is a Zurich-based non-profit medical association serving 20,000+ allergy and clinical immunology professionals across 142+ countries. It delivers congresses, focused meetings, peer-reviewed journals, the EAACI/UEMS Knowledge Exam, and digital learning platforms including EAACI Nexus and Knowledge Hub.
- Company typePrivate
- Founded1956
- HeadquartersZürich, Switzerland
- Headcount11–50
- GTM typeB2C
- OfferingServices
What European Academy of Allergy and Clinical Immunology does
EAACI (European Academy of Allergy and Clinical Immunology) is a Zurich-based non-profit professional medical association founded in 1956 in Florence and re-established under its current name in 1971. It serves more than 20,000 members (clinicians, researchers, and allied health professionals) across 142+ countries and coordinates with 54+ affiliated National Allergy Societies through a NAIS Committee. The organisation positions itself as the primary European reference body in allergy and clinical immunology, structured around 7 Sections (Asthma, Pediatrics, Dermatology, ENT, Basic & Clinical Immunology, Allied Health & Primary Care, JM Assembly) with multiple Interest Groups and Working Groups spanning food allergy, allergen immunotherapy, biologicals, mast cell diseases, and related disciplines.
Its core offering is a platform-plus-events model: flagship Annual Congresses (Istanbul 2026, prior London 2010 congress held 7,989 delegates; 2020 first digital congress served 8,000+ delegates), Focused Meetings (FAAM-EUROBAT-ISMA 2026 in Utrecht, SAM 2027 in Paris), Allergy and Winter Schools, plus the EAACI/UEMS Knowledge Exam administered online via ProctorU. Digital products include the EAACI Nexus learning platform, EAACI Knowledge Hub, MyEAACI member portal, virtual congress platform, and the EAACI Events mobile app. Journals (Allergy, Pediatric Allergy and Immunology, Clinical and Translational Allergy) are published in partnership with Wiley. Educational, fellowship, mentorship, and JM Quiz programmes target Junior Members, while the EAACI 3H Initiative integrates Research & Innovation, Public/Patients/Outreach, and Knowledge Hubs.
EAACI is funded by annual membership fees, event registrations, congress sponsorship and exhibitor revenue (including 16 founder sponsors at the Istanbul 2026 congress: ALK, AstraZeneca, Novartis, Sanofi Regeneron, GSK, Takeda, CSL, Stallergenes Greer, DBV Technologies, Blueprint Medicines, Celltrion, HAL Allergy, LETI Pharma, Neopharmed Gentili, Allergopharma, Allergy Therapeutics), Knowledge Exam fees, and journal publishing income. The organisation is governed by a 2026-2028 Executive Committee headed by President Mohamed Shamji and Secretary General María Escribese, operating under Swiss law with headquarters in Zurich (Hagenholzstrasse 111, established 2009) and an EU liaison office opened in 2014.
European Academy of Allergy and Clinical Immunology firmographics
Firmographics- Name
- European Academy of Allergy and Clinical Immunology
- Legal name
- European Academy of Allergy and Clinical Immunology
- Website
- https://eaaci.org
- Company type
- Private
- Founded year
- 1956
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- EAACI is a Zurich-based non-profit medical association serving 20,000+ allergy and clinical immunology professionals across 142+ countries. It delivers congresses, focused meetings, peer-reviewed journals, the EAACI/UEMS Knowledge Exam, and digital learning platforms including EAACI Nexus and Knowledge Hub.
- Ownership category
- akta.pro rank
Where European Academy of Allergy and Clinical Immunology is headquartered
LocationHeadquarters
- HQ city
- Zürich
- HQ country
- Switzerland
- HQ region
- Europe
Offices6 records
Markets served
European Academy of Allergy and Clinical Immunology business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure
Revenue model
- Membership Fees: EAACI operates as a membership-based professional association. Membership categories include regular members, Junior Members, and affiliates. Members receive access to journals, educational resources, discounted event registration, and professional networking opportunities
- Event Registration: Revenue from registration fees for Annual Congress, Focused Meetings, Allergy Schools, Winter Schools, and other EAACI events. Registration categories include regular participants, students, speakers, media representatives, and exhibitors. Member rates are discounted
- EAACI/UEMS Knowledge Exam: Annual certification exam in allergology and clinical immunology. Candidates pay registration and examination fees
- Sponsorship and Exhibitor Revenue: Corporate sponsorship of congresses and events. The EAACI Annual Congress 2026 lists 16 founder sponsors including ALK, Allergopharma, Allergy Therapeutics, AstraZeneca, CSL, Novartis, Sanofi Regeneron, Stallergenes Greer, DBV Technologies, GSK, Blueprint Medicines, Celltrion, HAL Allergy, LETI Pharma, Neopharmed Gentili, and Takeda
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Annual | EAACI Membership Categories |
| Subscription | Annual | Student Registration Rate |
| Other | Multi-year contract | FAAM-EUROBAT-ISMA 2026 Registration |
| Other | Pay-as-you-go | EAACI/UEMS Knowledge Exam 2026 |
Go-to-market motion1 record
Distribution channels6 records
Marketing channels8 records
European Academy of Allergy and Clinical Immunology product offering
Product offeringCore offering
EAACI is a non-profit professional medical association that serves clinicians, researchers, and allied health professionals in allergy and clinical immunology. It delivers membership services, scientific congresses, peer-reviewed journals (Allergy, PAI, CTA), digital learning platforms (Nexus, Knowledge Hub), certification exams, fellowship and mentorship programmes, and clinical practice guidelines.
Product overview
EAACI is a professional medical association (European Academy of Allergy and Clinical Immunology) with over 20,000 members from 142+ countries. The organization operates as a platform-plus-events model, offering scientific journals (Allergy, PAI, CTA via Wiley partnership), digital learning platforms (EAACI Nexus, EAACI Knowledge Hub), annual and focused congresses, educational programmes (Allergy College, Knowledge Exam), mentorship and fellowship programmes, and a member portal (MyEAACI). The EAACI 3H Initiative integrates research, patient outreach, and knowledge dissemination across the allergy and clinical immunology field.
Differentiator
Problem solved
Functional benefit
Brands
- EAACI Nexus: An exclusive platform providing dynamic learning modules, EAACI event archives, and personalized programmes for career development.
- EAACI3H
- EAACI Quality Centres
- EAACI/UEMS Knowledge Exam
Products and services
- EAACI Membership Annual membership subscription for clinicians, researchers, and allied health professionals in allergy and clinical immunology. Provides access to EAACI journals, discounted event registration, EAACI Nexus learning platform, fellowship and award programmes, mentorship, and international networking.
- EAACI Annual Congress Annual flagship scientific congress bringing together allergy and clinical immunology professionals for education, networking, research presentations, scientific sessions, exhibitions, awards, and CME accreditation.
- EAACI Journals Peer-reviewed scientific journals including Allergy, Pediatric Allergy and Immunology (PAI), and Clinical and Translational Allergy (CTA), published in partnership with Wiley.
- EAACI Nexus Online learning platform providing exclusive resources including dynamic learning modules, event archives, and personalised programmes for career development of EAACI members.
- EAACI Knowledge Hub Digital knowledge repository containing consensus documents, guidelines, position papers, and educational content for allergy and immunology professionals.
- EAACI/UEMS Knowledge Exam International examination assessing comprehensive knowledge in allergology and clinical immunology with 120 multiple-choice questions, recognised for professional credentialing across Europe.
- Allergy & Winter Schools Educational events providing specialized training in specific allergy topics at various locations throughout Europe.
- EAACI Focused Meetings Focused scientific meetings on specific allergy and immunology topics such as food allergy, anaphylaxis, mast cell disorders, biological therapies, and skin allergy.
- EAACI Mentorship Programme International mentorship programme connecting Junior Members with experienced EAACI professionals for career guidance, knowledge transfer, and scientific collaboration over a two-year period.
- EAACI Fellowship Programme Awards fellowships to Junior Members and trainees for increasing knowledge and skills at European scientific institutions, with reporting requirements on outcomes.
- EAACI Quality Centres Accreditation programme recognizing healthcare centres of excellence in allergy and clinical immunology that meet EAACI quality standards.
- EAACI Events App Mobile application for accessing EAACI congress schedules, abstracts, and event information, available on Apple App Store and Google Play Store.
- MyEAACI Portal Member management portal for EAACI members to manage accounts, membership, event registration, access journals, and download certificates.
- EAACI Allergy College Educational initiative for Junior Members providing specialized training and professional development in allergy and clinical immunology.
Companies that use European Academy of Allergy and Clinical Immunology
Customer profileNamed customers3 records
Segments5 records
Ideal customer profiles5 records
European Academy of Allergy and Clinical Immunology technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
European Academy of Allergy and Clinical Immunology partnerships and signals
Strategic signalPartnerships
22 partnerships are on record, tiered major, core and minor.
- EU FP6 / GA²LENmajorGA²LEN (Global Allergy and Asthma European Network) was established in the EAACI office in Brussels in 2003, sponsored by EU FP6. This EU research network advances allergy and asthma research collaboration.
- 54+ National Allergy SocietiescoreEAACI is affiliated with over 54 National Allergy Societies across Europe and globally. The NAIS Committee facilitates constant communication and collaboration on various projects and activities. These societies represent the primary national branches of EAACI in different countries.
- ALKmajorFounder sponsor of EAACI Annual Congress 2026. ALK is a pharmaceutical company specializing in allergy immunotherapy treatments.
- AstraZenecamajorFounder sponsor of EAACI Annual Congress 2026. AstraZeneca is a global pharmaceutical company with respiratory and immunology products.
- NovartismajorFounder sponsor of EAACI Annual Congress 2026. Novartis develops medicines and technologies for allergy and respiratory conditions.
- Sanofi RegeneronmajorFounder sponsor of EAACI Annual Congress 2026. Sanofi Regeneron develops Dupixent and other immunology therapies.
- GSKmajorFounder sponsor of EAACI Annual Congress 2026. GSK is a global healthcare company with respiratory and immunology portfolio.
- AllergopharmamajorFounder sponsor of EAACI Annual Congress 2026. Allergopharma specializes in allergy diagnosis and immunotherapy products.
- Allergy TherapeuticsmajorFounder sponsor of EAACI Annual Congress 2026. Allergy Therapeutics develops immunotherapies for allergies.
- CSLmajorFounder sponsor of EAACI Annual Congress 2026. CSL develops specialty biologics including immunoglobulin therapies.
- Stallergenes GreermajorFounder sponsor of EAACI Annual Congress 2026. Stallergenes Greer is a global immunotherapy company.
- DBV TechnologiesmajorFounder sponsor of EAACI Annual Congress 2026. DBV Technologies develops epicutaneous immunotherapy for food allergies.
- Blueprint MedicinesmajorFounder sponsor of EAACI Annual Congress 2026. Blueprint Medicines develops targeted therapies for severe diseases.
- CelltrionmajorFounder sponsor of EAACI Annual Congress 2026. Celltrion develops biosimilar and innovative biologic medicines.
- HAL AllergymajorFounder sponsor of EAACI Annual Congress 2026. HAL Allergy develops allergy immunotherapy products.
- LETI PharmamajorFounder sponsor of EAACI Annual Congress 2026. LETI Pharma specializes in allergy diagnosis and treatment products.
- Neopharmed GentilimajorFounder sponsor of EAACI Annual Congress 2026. Neopharmed Gentili operates in Italy with specialty pharmaceutical products.
- TakedamajorFounder sponsor of EAACI Annual Congress 2026. Takeda is a global pharmaceutical company with a focus on gastroenterology, oncology, neuroscience, and vaccines.
- WileycoreEAACI journals (Allergy, Pediatric Allergy and Immunology, Clinical and Translational Allergy) are published in partnership with Wiley. Members access journals through MyEAACI portal via Wiley platform.
- BnetworkminorOfficial hotel accommodation agent for EAACI congresses and focused meetings.
- UEMS (Union of European Medical Specialists)coreCo-development of the EAACI/UEMS Knowledge Exam for allergology and clinical immunology certification. UEMS provides financial support opportunities for eligible candidates.
- EACCME (European Accreditation Council for Continuing Medical Education)coreProvides CME accreditation for EAACI educational events and programs, ensuring high scientific and educational standards aligned with European and American CME systems.
Scale indicators7 records
Recent moves9 records
Expansion highlights5 records
European Academy of Allergy and Clinical Immunology competitors and assessment
Company assessmentDirect peers
- American Academy of Allergy, Asthma & Immunology: The primary US professional society for allergy and clinical immunology. Directly comparable in mission (membership, journals like JACI, annual meeting, CME, guideline-setting) and is the main counterpart to EAACI in North America.
- World Allergy Organization: Global umbrella federation of national and regional allergy/clinical immunology societies, including EAACI as a member. Comparable as an international membership body publishing the WAO Journal and running the World Allergy Congress.
- American College of Allergy, Asthma & Immunology: Second major US allergy/clinical immunology society, also publishing a peer-reviewed journal and running an annual scientific meeting. Comparable to EAACI in scale, mission, and member-base structure in North America.
Broad incumbents
- European Respiratory Society: Large European professional society covering respiratory medicine, with overlapping scope in asthma and respiratory allergy. Comparable as a European membership/education/events body serving pulmonologists, an adjacent specialty to EAACI's audience.
- European Society for Paediatric Research: European professional society for paediatric research, with overlapping membership base in paediatric allergy. Comparable in structure (European professional society, congress, journal, research grants) and in shared audience with EAACI's Pediatrics Section.
- European Society of Clinical Microbiology and Infectious Diseases: Large European clinical society running congresses (ECCMID), journals, and educational programs. Comparable as a European specialty society operating on a similar membership/events/publication model to EAACI, though in a different clinical domain.
- European Society for Medical Oncology: Leading European professional society for medical oncology, with congresses, journals, and guideline programs. Comparable to EAACI as a European specialty society with strong pharma sponsorship, congress, and guideline-setting authority, though in oncology.
Regional players
- British Society for Allergy and Clinical Immunology: UK national society for allergy and clinical immunology, affiliated with EAACI via the NAIS Committee. Comparable in offering UK-focused membership, meetings, and guidelines, but operating at a national rather than European level.
- Asia Pacific Association of Allergy, Asthma and Clinical Immunology: Regional society representing allergy/clinical immunology professionals across Asia Pacific. Comparable as a regional professional association with congresses and journals, but focused on Asia Pacific rather than Europe.
- Latin American Society of Allergy, Asthma and Immunology: Regional professional society for allergy and clinical immunology across Latin America. Comparable in mission and member offerings (congress, journal, training) but focused on a different geographic region than EAACI.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks6 records
Key highlights7 records
Customer concentration
European Academy of Allergy and Clinical Immunology social profiles
Digital presenceEuropean Academy of Allergy and Clinical Immunology compliance and trust
Trust signalCompliance2 records
European Academy of Allergy and Clinical Immunology financial estimates
Financial estimateRevenue estimate
Valuation estimate
European Academy of Allergy and Clinical Immunology leadership team
Management profileNumber of profiles
Profiles9 records
European Academy of Allergy and Clinical Immunology subsidiaries and ownership
Company hierarchySubsidiaries4 records
European Academy of Allergy and Clinical Immunology funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
European Academy of Allergy and Clinical Immunology M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about European Academy of Allergy and Clinical Immunology
What does European Academy of Allergy and Clinical Immunology do?
EAACI is a non-profit professional medical association that serves clinicians, researchers, and allied health professionals in allergy and clinical immunology. It delivers membership services, scientific congresses, peer-reviewed journals (Allergy, PAI, CTA), digital learning platforms (Nexus, Knowledge Hub), certification exams, fellowship and mentorship programmes, and clinical practice guidelines.
Is European Academy of Allergy and Clinical Immunology a public or private company?
European Academy of Allergy and Clinical Immunology is a private company. It is classified as nonprofit foundation owned and is currently operating.
When was European Academy of Allergy and Clinical Immunology founded?
European Academy of Allergy and Clinical Immunology was founded in 1956. It employs 11 to 50 people.
Where is European Academy of Allergy and Clinical Immunology based?
European Academy of Allergy and Clinical Immunology is headquartered in Zürich, Switzerland, in the Europe region.
How does European Academy of Allergy and Clinical Immunology make money?
Four revenue lines are on record. Membership Fees are the primary driver. The others are event Registration, EAACI/UEMS Knowledge Exam and sponsorship and Exhibitor Revenue.
Who are European Academy of Allergy and Clinical Immunology's main competitors?
Direct peers on record are American Academy of Allergy, Asthma & Immunology, World Allergy Organization and American College of Allergy, Asthma & Immunology. Broad incumbents are European Respiratory Society, European Society for Paediatric Research, European Society of Clinical Microbiology and Infectious Diseases and European Society for Medical Oncology. Regional players are British Society for Allergy and Clinical Immunology, Asia Pacific Association of Allergy, Asthma and Clinical Immunology and Latin American Society of Allergy, Asthma and Immunology.
Does European Academy of Allergy and Clinical Immunology have an API?
No public API is recorded for European Academy of Allergy and Clinical Immunology.